Efacid

Efacid is an oral antacid suspension developed by Strassenburg Pharmaceuticals for the management of acid reflux and heartburn. It is a fixed-dose combination containing magaldrate, light magnesium carbonate, and sodium alginate. Magaldrate, a hydroxymagnesium aluminate complex, rapidly and sustainably neutralizes excess gastric acid, raising the stomach pH. Light magnesium carbonate acts as an additional antacid to neutralize gastric acidity and provides a mild laxative effect to counteract the constipating properties of aluminum-containing antacids. Sodium alginate reacts with gastric acid to form a viscous, low-density gel raft that floats on top of the stomach contents, creating a physical barrier that prevents the reflux of acidic gastric contents into the esophagus. Together, these components provide rapid and prolonged relief from gastrointestinal discomfort associated with hyperacidity and gastroesophageal reflux.

Brand names

EfacidEfacid Suspension

Other names

magaldrate + light magnesium carbonate + sodium alginatemagaldrate + magnesium aluminium silicate hydrate + sodium alginatemagaldrate + magnesium carbonate + sodium alginate